Bibliography
- Weiner L : An overview of monoclonal antibody therapy of cancer.Semin. Oncol.26(4 Suppl. 12) , 41–50 (1999).
- Druker BJ : Translation of the Philadelphia chromosome into therapy for CML.Blood112(13) , 4808–4817 (2008).
- Ritter C , ArteagaC: The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors.Semin. Oncol.30(1 Suppl. 1) , 3–11 (2003).
- Jain RK , DudaDG, ClarkJW, LoefflerJS: Lessons from Phase III clinical trials on anti-VEGF therapy for cancer.Nat. Clin. Prac. Oncol.3(1) , 24–40 (2006).
- Lane AA , ChabnerBA: Histone deacetylase inhibitors in cancer therapy.J. Clin. Oncol.27(32) , 5459–5468 (2009).
- Lennard L , LilleymanJ, LoonJV, WeinshilboumR: Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.Lancet336(8709) , 225–229 (1990).
- Hoskins J , GoldbergR, QuP, IbrahimJ, McleodH: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.J. Natl Cancer Inst.99(17) , 1290–1295 (2007).
- Goetz MP , RaeJM, SumanVJ et al.: Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.J. Clin. Oncol.23(36) , 9312–9318 (2005).
- Dolan ME , NewboldKG, NagasubramanianR et al.: Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity.Cancer Res.64(12) , 4353–4356 (2004).
- Watters JW , KrajaA, Meucci Ma, Province MA, Mcleod HL: Genome-wide discovery of loci influencing chemotherapy cytotoxicity. Proc. Natl Acad. Sci. USA101(32) , 11809–11814 (2004).
- McPherson JD , MarraM, HillierL et al.: A physical map of the human genome.Nature409(6822) , 934–941 (2001).
- Cancer Genome Atlas Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature455(7216) , 1061–1068 (2008).
- Morris S , CareyL: Gene expression profiling in breast cancer.Curr. Opin. Oncol.19(6) , 547–551 (2007).
- Thomas RK , WeirB, MeyersonM: Genomic approaches to lung cancer.Clin. Cancer Res.12(14) , S4384–S4391 (2006).
- Holleman A , Den Boer Ml, De Menezes RX et al.: The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood107(2) , 769–776 (2006).
- Holleman A , CheokM, Den Boer M et al.: Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N. Engl. J. Med.351(6) , 533–542 (2004).
- Potti A , DressmanHK, BildA et al.: Genomic signatures to guide the use of chemotherapeutics.Nat. Med.12(11) , 1294–1300 (2006).
- Huang RS , DuanS, ShuklaSJ et al.: Identification of genetic variants contributing to cisplatin-induced cytotoxicity using a genome-wide approach.Am. J. Hum. Genet.81(3) , 427–437 (2007).
- Huang Y -T, Heist RS, Chirieac LR et al.: Genome-wide analysis of survival in early-stage non-small-cell lung cancer. J. Clin. Oncol.27(16) , 2660–2667 (2009).
- Yang JJ , BhojwaniD, YangW et al.: Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.Blood112(10) , 4178–4183 (2008).
- Zhang Y , MartensJWM, YuJX et al.: Copy number alterations that predict metastatic capability of human breast cancer.Cancer Res.69(9) , 3795–3801 (2009).
- Duan S , HuangR, ZhangW et al.: Genetic architecture of transcript-level variation in humans.Am. J. Hum. Genet.82(5) , 1101–1113 (2008).
- International Hapmap Consortium; Frazer K, Ballinger D, Cox DR et al.: A second generation human haplotype map of over 3.1 million SNPs. Nature449(7164) , 851–861 (2007).